Ezogabine: A New Angle On Potassium Gates

被引：14
作者：
Faught, Edward [1 ]
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
来源：
EPILEPSY CURRENTS | 2011年 / 11卷 / 03期
关键词：
ANTICONVULSANT RETIGABINE; EPILEPSY; SEIZURES; CHANNEL; D-23129; MODEL; EFFICACY; BINDING; SAFETY; KCNQ2;
D O I：
10.5698/1535-7511-11.3.75
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Ezogabine is a new drug for adjunctive therapy of partial-onset seizures with a novel mechanism of action. As a potassium-channel facilitator, it promotes membrane repolarization and thus opposes rapid repetitive discharges. Side effects are typical for antiepileptic drugs and the safety profile is good. Occasional instances of urinary difficulty may require surveillance.
引用
收藏
页码：75 / 78
页数：4
相关论文
共 26 条
  • [1] THE AMERICAN-UROLOGICAL-ASSOCIATION SYMPTOM INDEX FOR BENIGN PROSTATIC HYPERPLASIA
    BARRY, MJ
    FOWLER, FJ
    OLEARY, MP
    BRUSKEWITZ, RC
    HOLTGREWE, HL
    MEBUST, WK
    COCKETT, ATK
    BLAIVAS, JG
    WEIN, AJ
    [J]. JOURNAL OF UROLOGY, 1992, 148 (05) : 1549 - 1557
  • [2] Ben-Menachem Elinor, 2007, Epilepsy Curr, V7, P153, DOI 10.1111/j.1535-7511.2007.00209.x
  • [3] Potassium channels Brief overview and implications in epilepsy
    Benarroch, Eduardo E.
    [J]. NEUROLOGY, 2009, 72 (07) : 664 - 669
  • [4] Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: Systematic review and meta-analysis
    Beyenburg, Stefan
    Stavem, Knut
    Schmidt, Dieter
    [J]. EPILEPSIA, 2010, 51 (01) : 7 - 26
  • [5] Brickel N., 2010, PHARM EFFECTS RETIGA
  • [6] Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy
    Brodie, M. J.
    Lerche, H.
    Gil-Nagel, A.
    Elger, C.
    Hall, S.
    Shin, P.
    Nohria, V.
    Mansbach, H.
    [J]. NEUROLOGY, 2010, 75 (20) : 1817 - 1824
  • [7] Neural KCNQ (Kv7) channels
    Brown, David A.
    Passmore, Gayle M.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2009, 156 (08) : 1185 - 1195
  • [8] Dost R, 2000, EPILEPSY RES, V38, P53
  • [9] Lack of pharmacokinetic interaction between retigabine and phenobarbitone at steady-state in healthy subjects
    Ferron, GM
    Patat, A
    Parks, V
    Rolan, P
    Troy, SM
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (01) : 39 - 45
  • [10] Multiple-dose, linear, dose-proportional pharmacokinetics of retigabine in healthy volunteers
    Ferron, GM
    Paul, J
    Fruncillo, R
    Richards, L
    Knebel, N
    Getsy, J
    Troy, S
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (02) : 175 - 182
123